MANKIND:NSE
Mankind Pharma Ltd
₹2,370.60
arrow_downward
-0.39%(-9.40) 1D
Oct 9, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MANKIND...
Open
₹2,380.00
High
₹2,389.80
Low
₹2,342.00
Mkt. cap
977.45B
Avg. vol.
491.07K
Volume
306.90K
P/E ratio
47.97
52-wk high
₹2,642.00
52-wk low
₹1,909.70
EPS
₹49.42
No. of employees
20K
Open
₹2,380.00
High
₹2,389.80
Low
₹2,342.00
Mkt. cap
977.45B
Avg. vol.
491.07K
Volume
306.90K
P/E ratio
47.97
52-wk high
₹2,642.00
52-wk low
₹1,909.70
EPS
₹49.42
No. of employees
20K
News stories
From web sources and news partners
Seeking Alpha
·
35 minutes ago
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
Simply Wall Street
·
41 minutes ago
Webull And 2 More Founder Led Stocks To Watch
The Motley Fool
·
56 minutes ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
Yahoo Finance
·
23 hours ago
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20.5K
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitemankindpharma.com